Currently, there is a need for reliable tests that allow identification of individuals that have
been infected with SARS-CoV-2 even if the infection was asymptomatic. To date, the vast …

Background ALK rearrangements are present in 5% of nonsmall cell lung cancer (NSCLC)
tumors and identify patients who can benefit from ALK inhibitors. ALK fusions testing using …

Multiple questions about SARS-CoV-2 humoral and cellular immunity remain unanswered.
One key question is whether preexisting memory T or B cells, specific for related …

Here, we describe a new, simple, highly multiplexed serological test that generates a more
complete picture of seroconversion than single antigen‐based assays. Flow cytometry is …

Most human cells release extracellular vesicles (EVs) of different sizes and composition,
containing biomolecules characteristic from the originating tissue. In consequence, when EVs …

Background Extracellular vesicles (EVs), released by most cell types, provide an excellent
source of biomarkers in biological fluids. However, in order to perform validation studies and …

Currently, there is a need for reliable tests that allow identification of individuals that have
been infected with SARS-CoV-2 even if the infection was asymptomatic. To date, the vast …

Las células asesinas naturales también conocidas como NK presentan actividad citotóxica
frente a células infectadas por virus y frente a células tumorales del organismo. Estos últimos …

Many new aspects of COVID-19 disease, including different clinical manifestations, have
been identified during the pandemic. The wide array of symptoms and variation in disease …

Background: Identification of ALK rearrangements in NSCLC patients has important implications
as it significantly expands their therapeutic opportunities. However, the availability of …